Testosterone Therapy for Women in NYC: What the Evidence Supports in Perimenopause and Menopause

Many women in their forties and fifties tell us the same thing in slightly different words: desire has gone quiet, energy is flat, and the estrogen they started has helped the hot flashes but not everything else. Testosterone is often the next question. This guide to testosterone therapy for women in NYC explains what the research actually supports, how female dosing differs from male dosing, what side effects to watch for, and how we decide whether testosterone makes sense for a particular patient. It is written to be honest about limits as well as benefits, because testosterone for women is one of the areas in hormone medicine where marketing has run well ahead of the evidence.

One fact frames everything below. In the United States, the FDA has not approved any testosterone product for women. Every prescription of testosterone to a woman in this country is off-label. That does not make it improper, since off-label prescribing is common and legitimate in medicine, but it does mean the dose, the product, and the monitoring plan all depend on the judgment of the clinician, and you deserve to understand how that judgment is made.

Why Women Make Testosterone, and What Happens to It With Age

Testosterone is not a male hormone that women happen to carry in small amounts. It is a normal female hormone, produced by the ovaries and the adrenal glands, and in premenopausal women circulating testosterone levels are actually higher than estradiol levels on a molar basis. It contributes to sexual desire and arousal, and receptors for it are present in brain, muscle, bone, skin, and hair follicles.

What surprises many patients is that female testosterone does not fall off a cliff at menopause the way estrogen does. Levels decline gradually from the twenties onward, so a woman of fifty typically has roughly half the testosterone she had at twenty to twenty-five. The ovaries keep producing some testosterone after the final menstrual period. The exception is surgical menopause: women whose ovaries are removed lose that ovarian contribution suddenly, and they tend to notice a sharper change in libido.

Two other factors matter. Oral estrogen, including many birth control pills and oral menopausal hormone therapy, raises sex hormone binding globulin (SHBG), the protein that binds testosterone in the blood. Higher SHBG means less free, active testosterone. Thyroid disease, weight changes, and some medications shift SHBG as well. This is one reason a single testosterone number, read without context, can mislead.

The broader picture of hormonal aging is covered on our menopause care page, which explains how we approach estrogen, progesterone, sleep, and symptom management as a whole. Testosterone is one piece of that picture, and for most women it is not the first piece.

Perimenopause vs. Menopause: Where Testosterone Fits

Perimenopause is the transition, often lasting several years, when cycles become irregular and estrogen and progesterone swing unpredictably. Menopause is defined as twelve months without a period. The distinction matters for testosterone because the evidence base is not the same for both groups.

For women searching for perimenopause treatment in NYC, the honest message is that testosterone is rarely where we start. Hot flashes, night sweats, broken sleep, heavy or irregular bleeding, and mood changes usually respond to other measures first. When a perimenopausal woman has persistent, distressing loss of desire after those issues are addressed, testosterone can be discussed, but we explain that the data in this group are thinner and the decision is more individual.

The Evidence Base: The 2019 Global Consensus Position Statement

In 2019, an international group of experts published the Global Consensus Position Statement on the Use of Testosterone Therapy for Women. It was developed with and endorsed by a long list of medical societies, including the International Menopause Society, the Endocrine Society, and what is now The Menopause Society, and it was published in several major journals at once. It remains the most widely cited summary of the field.

Its central conclusions are worth knowing in plain terms.

What the statement supports

The only evidence-based indication for testosterone in women is hypoactive sexual desire disorder (HSDD) in postmenopausal women. HSDD means low or absent sexual desire that causes personal distress and is not better explained by another medical condition, a medication, relationship problems, or depression. In randomized trials, testosterone at doses that produce blood levels in the normal premenopausal range improved sexual desire, arousal, orgasm, pleasure, and the number of satisfying sexual events, and reduced sexual distress. The benefit was real but moderate. It is not a switch that restores the libido of a twenty-five-year-old.

What the statement does not support

The authors found insufficient evidence to recommend testosterone for low energy, general wellbeing, mood, cognition, bone protection, or muscle strength in women. They also did not recommend testosterone for premenopausal women because of a lack of data, and they advised against using a blood testosterone level by itself to diagnose HSDD, because levels do not neatly predict who has symptoms.

What it says about products

The statement recommended against compounded testosterone products and against implants (pellets) and injections, because these can produce levels well above the female physiologic range and their dosing is less predictable. Oral testosterone was not recommended because of its unfavorable effect on cholesterol. Transdermal preparations, applied to the skin, were preferred. Where no approved female product exists, as in the United States, the authors accepted careful use of an approved male product at a small fraction of the male dose, with blood monitoring.

That guidance shapes how we practice, and it explains why some of what women hear about testosterone, especially claims about energy, weight, and anti-aging, is not supported. If you are reading about the hidden signs your hormones are aging, keep in mind that many of those signs have more than one cause, and testosterone is only proven for one of them.

Low Libido in Menopause: Is It Really a Testosterone Problem?

Sexual desire is shaped by hormones, but also by sleep, stress, pain, relationship dynamics, body image, depression, and medications. Before considering testosterone, we look at each of these, because treating the wrong cause gives disappointing results.

Common contributors we screen for include:

• Genitourinary syndrome of menopause. Low estrogen thins vaginal and vulvar tissue, causing dryness and pain with intercourse. When sex hurts, desire understandably fades. Local vaginal estrogen or other treatments for dryness often matter more than testosterone here.
• Medications. SSRIs and SNRIs, some blood pressure drugs, and oral contraceptives can reduce desire or arousal.
• Sleep disruption. Night sweats and insomnia are among the most common menopause complaints, and chronic exhaustion suppresses libido.
• Mood. Depression and anxiety reduce desire and need their own treatment.
• Thyroid disease and anemia. Both cause fatigue and low drive and are simple to test.
• Relationship and life factors. Caregiving, long work hours in a demanding city, partner health, and unresolved conflict all play a role, and none of them respond to hormones.

When these are addressed and low desire persists and causes distress, a trial of testosterone is reasonable for a postmenopausal woman. Many women find that restoring estrogen first improves sleep, comfort, and mood enough that desire returns partly on its own. Our article on how BHRT can improve more than just your mood discusses that wider effect.

Does low testosterone cause hot flashes in women?

Hot flashes in women are driven mainly by falling and fluctuating estrogen acting on the brain's temperature control center. Low testosterone is not a recognized cause of hot flashes in women, and testosterone is not a treatment for them. If hot flashes are your main symptom, estrogen therapy (or a non-hormonal option when estrogen is not appropriate) is the evidence-based route.

Fatigue and Testosterone: Can Too Much Testosterone Make You Tired in Women?

Fatigue brings many women to our office, and searches like "menopause fatigue treatment NYC" reflect how common it is. It is also where expectations about testosterone most often go wrong.

First, testosterone is not proven to treat fatigue in women. Some women report feeling more energetic on it, and that may be real for them, but controlled trials have not shown a reliable energy benefit, and the consensus statement did not support prescribing it for that purpose.

Second, the question of whether too much testosterone can make a woman tired comes up often, and the honest answer is that it can contribute indirectly. There is no clear evidence that physiologic doses cause fatigue. At higher, supraphysiologic levels, though, several mechanisms can leave someone feeling worse rather than better:

• Sleep disruption. Some women report restlessness, vivid dreams, or poorer sleep with higher doses, and excess androgens have been associated with worsening sleep-disordered breathing in some people.
• Mood effects. Irritability and agitation are reported at higher levels, and poor mood and fatigue travel together.
• Red blood cell changes. Testosterone stimulates red cell production. Significant elevation is far more typical of male dosing, but very high doses in women can thicken the blood, and that is checked on bloodwork.

The practical point: if you are on testosterone and feel more tired, it is a reason to check your levels and your dose, not to add more. If you are not on testosterone and feel exhausted, the workup should include thyroid function, iron and ferritin, vitamin B12, blood count, sleep quality, and screening for sleep apnea and depression. Our article on warning signs of a testosterone imbalance outlines the signs of high and low testosterone that can overlap with these other conditions.

Female Physiologic Dosing: Why Male Products Are Not Appropriate As Prescribed

The goal of testosterone therapy for women is narrow: bring blood levels back into the normal range for a healthy premenopausal woman, not above it. Female testosterone levels are roughly one tenth to one twentieth of normal male levels, and the doses used in trials reflect that. A woman needs a small fraction of a typical male daily dose.

This is why using a male product as labeled is not appropriate for women. A standard male gel dose, a male injection, or a male pellet would push a woman's levels many times above the female range, and that is where the meaningful side effects appear. Where a male transdermal product is used off-label, the clinician must prescribe a precise fraction of the male dose and confirm with bloodwork that levels stay in the female range.

A few practical dosing points:

• Route matters. Applying testosterone to the skin produces relatively steady levels. Oral testosterone is avoided because of its effect on cholesterol and the liver.
• Time course. Changes in desire, when they happen, usually appear over several weeks. The consensus statement suggested reassessing at around six months and stopping if there is no meaningful benefit.
• Duration. Safety data from trials extend to about two years. Longer-term use is reasonable for some women who benefit, with ongoing monitoring, but long-term safety data are limited and we say so.

Testosterone and Estrogen and Progesterone: How It Fits With BHRT

For most women, testosterone is an add-on to estrogen-based menopause care, not a replacement for it. Estrogen is the treatment for hot flashes, night sweats, vaginal dryness, and the bone loss that accelerates after menopause. Women with a uterus who take estrogen also need a progestogen, such as micronized progesterone, to protect the uterine lining.

Testosterone interacts with this regimen in a few ways. Oral estrogen raises SHBG, which binds testosterone and can blunt its effect, so women on oral estrogen sometimes do better when their estrogen is switched to a transdermal patch or gel. Some women's libido improves enough on estrogen alone that testosterone is never needed.

Bioidentical hormones are a frequent topic among women considering BHRT in NYC. Our article on reasons bioidentical hormone replacement therapy may be right for you covers the broader rationale. For testosterone specifically, it helps to know that the testosterone molecule in approved products is already identical to the hormone your body makes. The more important questions are dose accuracy, consistency between batches, and monitoring.

Women who should generally avoid testosterone, or use it only after specialist discussion, include those with a history of hormone-sensitive breast cancer, active liver disease, pregnancy or plans for pregnancy, and significant acne, hirsutism, or androgen-related scalp hair loss already present. Women with cardiovascular disease need individualized discussion, since long-term cardiovascular data in women are limited.

Side Effects: Acne, Hair Growth, Voice, and What Is Reversible

At physiologic female doses, side effects in trials were uncommon and usually mild. They become more likely and more pronounced when levels run above the female range.

Voice change and clitoral enlargement are the side effects we take most seriously because they may be permanent. They are associated with excessive dosing, which is the strongest argument for female-specific dosing and regular blood tests. Any hoarseness or change in vocal pitch is a reason to stop and call.

The link between testosterone, pubic hair, and body hair

A large share of the women who find our site are searching for answers about pubic hair thinning, so this connection deserves a clear explanation. Pubic and underarm hair are androgen-dependent: their growth at puberty is driven by adrenal and ovarian androgens. As androgen and estrogen levels decline with age, many women notice that pubic hair becomes sparser, finer, and grayer. This is one reason women lose pubic hair as they age, and why pubic hair loss in perimenopause is common. Sudden or patchy loss warrants evaluation, and our article on where your hair falls out when the cause is hormonal walks through the patterns.

We do not prescribe testosterone to restore pubic hair. Increased body hair is a side effect, not a goal, and pursuing it would mean raising levels toward the range where unwanted facial hair and other effects appear. If hair thinning is part of a broader picture that includes distressing low desire after menopause, it becomes part of the conversation, but it is not the indication.

Monitoring Bloodwork: What We Check and When

Because testosterone for women is off-label and the margin between helpful and excessive is narrow, monitoring is not optional. The consensus statement recommended measuring total testosterone before starting and again after about three to six weeks, then periodically, roughly every six months, to make sure levels are not running above the premenopausal range.

A typical monitoring approach includes:

1. Baseline total testosterone, ideally measured by a method validated for the low levels found in women (liquid chromatography with mass spectrometry is preferred, since some immunoassays are inaccurate at female levels).
2. SHBG, to help interpret total testosterone and estimate free testosterone.
3. Estradiol and, where relevant, FSH, to understand menopausal status and the effect of any estrogen therapy.
4. Thyroid function, blood count, iron studies, and metabolic markers, since these overlap with fatigue and libido symptoms.
5. Lipids and liver tests, often checked at baseline, particularly if there are risk factors.
6. Repeat testosterone at three to six weeks, then about every six months, plus a clinical check of skin, hair, voice, and mood.

Self-Assessment: Is Testosterone Worth Discussing?

This checklist is not a diagnosis, but it helps organize your thoughts before a visit. Tally which statements are true for you.

Statements that make testosterone worth discussing:

• I am postmenopausal (twelve months or more without a period, or I have had my ovaries removed).
• My sexual desire has clearly declined compared with earlier in my life.
• This change bothers me personally, not just because of what others expect.
• It has lasted six months or longer.
• Vaginal dryness or pain has been treated, or is not a factor.
• My sleep, mood, and thyroid have been checked or are not likely causes.
• I am on, or have considered, estrogen therapy for my other symptoms.
• I am willing to have regular bloodwork and to stop if it does not help within about six months.

Statements that suggest a different first step or extra caution:

• I am still having periods, even irregular ones.
• My main complaints are hot flashes, night sweats, or insomnia.
• My main hope is more energy, weight loss, or better muscle tone.
• I have a history of breast cancer or another hormone-sensitive cancer.
• I already have acne, facial hair growth, or thinning scalp hair.
• I am taking oral estrogen or an oral contraceptive.
• I may want to become pregnant.

If most of the first list applies and little of the second, testosterone is a reasonable topic for a consultation. If several of the second list apply, we will likely start elsewhere, and that is not a refusal. It is the order in which the evidence suggests the best results.

Testosterone Therapy for Women in NYC: What a Consultation Looks Like

Women seeking hormone therapy in New York City often describe a frustrating split: their gynecologist focuses on screening and bleeding, their primary care physician focuses on blood pressure and cholesterol, and nobody has time for a full conversation about desire, energy, sleep, and hormones together. A focused visit tries to fill that gap.

In practice, a first visit covers:

• Your history: menstrual pattern, surgeries (especially hysterectomy or removal of ovaries), pregnancies, cancers in you and your family, clotting history, and current medications and supplements.
• Your symptoms in detail: what changed, when, how much it bothers you, and what you have already tried.
• Sexual health: asked respectfully and directly, because vague questions get vague answers.
• Lifestyle factors that are particular to city life: long work hours, commuting, irregular sleep, and high stress all influence the symptoms women attribute to hormones.
• Bloodwork: ordered to answer specific questions rather than as a large panel for its own sake.
• A plan with a timeline: what we will try first, when we will recheck, and what result would make us continue or stop.

Patients who want to know more about the physician's background in hormone medicine can read about Dr. Lionel Bissoon before booking.

A Realistic Timeline for Testosterone Therapy

Setting expectations at the start avoids disappointment later. A typical sequence for a postmenopausal woman with HSDD looks like this:

• Weeks 0 to 2: Consultation, baseline labs, treatment of any contributing factors such as vaginal dryness or sleep issues, and review of estrogen route.
• Weeks 3 to 6: Start transdermal testosterone at a female dose; repeat testosterone level to confirm it sits within the premenopausal range.
• Weeks 6 to 12: Early changes in desire or responsiveness may begin for some women; dose adjusted only if levels and symptoms suggest it.
• Around 6 months: Formal review. If there has been no meaningful improvement, testosterone is stopped. If there has, it may continue with monitoring roughly every six months.
• Ongoing: Periodic labs, skin and hair checks, voice check, breast and cardiovascular screening as recommended for your age.

Summing up

At Liondale Medical, Dr. Lionel Bissoon treats testosterone for women as a targeted therapy rather than a general energy or anti-aging tool. That means confirming the indication, addressing estrogen, sleep, and other contributors first, using a female physiologic dose rather than a male product as labeled, and keeping levels in range with scheduled bloodwork. It also means telling patients plainly when testosterone is unlikely to help, and stopping it when it does not.

If low desire, fatigue, or changes in your hair and body have you wondering whether your hormones are part of the story, the most useful next step is an evaluation that looks at the whole picture.

Frequently Asked Questions

Is testosterone therapy for women FDA approved?

No. The FDA has not approved any testosterone product for women in the United States, so all testosterone prescribed to women here is off-label. Off-label prescribing is legal and common, but it places responsibility on the clinician to choose a female-appropriate dose, use a reliable product, and monitor blood levels. Some other countries, such as Australia, have approved a testosterone product for women, and international guidelines support carefully dosed use for postmenopausal women with hypoactive sexual desire disorder.

What did the 2019 Global Consensus Position Statement conclude?

The statement, endorsed by many international medical societies, concluded that the only evidence-based use of testosterone in women is hypoactive sexual desire disorder in postmenopausal women. In that group, physiologic doses moderately improved desire, arousal, orgasm, and satisfying sexual events. It found insufficient evidence to recommend testosterone for energy, mood, cognition, bone, or muscle, did not recommend it for premenopausal women, preferred transdermal products, and advised against pellets, injections, and compounded products because of unpredictable or excessive levels.

Can too much testosterone make you tired in women?

It can contribute indirectly. Physiologic doses are not known to cause fatigue, but levels above the female range may disrupt sleep, cause irritability, and in rare cases raise red blood cell counts, all of which can leave you feeling worse. Pellets and injections can also produce peaks and troughs that some women experience as feeling wired and then drained. If you feel more tired on testosterone, have your level checked and your dose reviewed rather than increasing it.

Can high testosterone in women cause fatigue even without treatment?

Naturally high testosterone in women is most often related to polycystic ovary syndrome, which commonly comes with insulin resistance, weight changes, and poor sleep. Fatigue in that setting is usually tied to the metabolic and sleep picture rather than testosterone directly. Fatigue should always prompt a broader workup, including thyroid function, iron and ferritin, vitamin B12, blood count, mood screening, and an assessment for sleep apnea, before hormones are blamed.

Will testosterone help my energy and weight during menopause?

Some women report feeling more energetic on testosterone, but controlled trials have not shown a reliable benefit for energy, weight, or general wellbeing, and international guidance does not recommend it for those purposes. Energy and weight in menopause are more often affected by sleep disruption, hot flashes, thyroid function, iron levels, muscle loss, and stress. Estrogen therapy, strength training, sleep treatment, and nutrition usually do more for these concerns than testosterone does.

Why can't women simply use a men's testosterone product?

A man's dose would raise a woman's testosterone many times above the normal female range. Women naturally have roughly one tenth to one twentieth of male levels, so the appropriate dose is a small fraction of a male dose. At male doses, women are at real risk of acne, facial hair, scalp hair thinning, voice deepening, and clitoral enlargement, and the last two may be permanent. A male transdermal product can be used off-label only at a carefully measured female dose with blood monitoring.

Does testosterone cause pubic hair to grow back?

Testosterone can increase body hair growth, but it is not prescribed to restore pubic hair, because pushing levels high enough to regrow hair also raises the risk of unwanted facial hair and other androgen effects. Gradual pubic hair thinning with age is common and reflects declining androgen and estrogen levels. Sudden or patchy loss, or loss with other symptoms, should be evaluated for thyroid disease, iron deficiency, autoimmune hair loss, medication effects, or other hormonal causes.

What bloodwork is needed for testosterone therapy in women?

Before starting, most clinicians check total testosterone, ideally with a mass spectrometry method accurate at female levels, plus SHBG, estradiol, and tests relevant to your symptoms such as thyroid function and blood count. Testosterone is rechecked about three to six weeks after starting and then roughly every six months to confirm levels stay within the premenopausal range. The blood level is mainly a safety check; the decision to treat rests on symptoms and history.

Can I take testosterone during perimenopause?

The research supporting testosterone was done mostly in postmenopausal women, and the 2019 consensus did not recommend it for premenopausal women because of limited data. During perimenopause, the usual priorities are cycle and bleeding management, hot flashes, sleep, mood, and contraception. If distressing low desire persists after those are addressed, testosterone can be discussed on an individual basis, with clear expectations about the thinner evidence and careful monitoring.

How long does it take for testosterone to work in women?

When testosterone helps, women usually notice gradual changes in desire and responsiveness over several weeks, with the full effect assessed at around six months. International guidance suggests stopping testosterone if there is no meaningful improvement by then. Trial safety data extend to about two years, so women who continue longer do so with ongoing monitoring of blood levels, skin, hair, voice, and routine breast and cardiovascular screening.

This page was written and medically reviewed by Lionel Bissoon, D.O., founder of Liondale Medical. Dr. Bissoon is a board-certified osteopathic physician specializing in anti-aging and concierge medicine on the Upper West Side of Manhattan.

This content is for educational purposes only and does not constitute medical advice. Individual results may vary. Consult a qualified physician before beginning any new treatment.

Published October 6th, 2026